H&Q HEALTHCARE INVESTORS
NSAR-B, EX-27, 2000-11-21
Previous: H&Q HEALTHCARE INVESTORS, NSAR-B, EX-23, 2000-11-21
Next: LECTEC CORP /MN/, 8-K, 2000-11-21



<TABLE> <S> <C>

<ARTICLE>                     6

<S>                                                      <C>
<PERIOD-TYPE>                                                 12-MOS
<FISCAL-YEAR-END>                                        SEP-30-2000
<PERIOD-START>                                           OCT-01-1999
<PERIOD-END>                                             SEP-30-2000
<INVESTMENTS-AT-COST>                                    141,741,276
<INVESTMENTS-AT-VALUE>                                   485,210,062
<RECEIVABLES>                                                904,339
<ASSETS-OTHER>                                               312,603
<OTHER-ITEMS-ASSETS>                                               0
<TOTAL-ASSETS>                                           486,427,004
<PAYABLE-FOR-SECURITIES>                                           0
<SENIOR-LONG-TERM-DEBT>                                            0
<OTHER-ITEMS-LIABILITIES>                                          0
<TOTAL-LIABILITIES>                                          844,434
<SENIOR-EQUITY>                                                    0
<PAID-IN-CAPITAL-COMMON>                                 144,487,457
<SHARES-COMMON-STOCK>                                     10,522,490
<SHARES-COMMON-PRIOR>                                     10,174,647
<ACCUMULATED-NII-CURRENT>                                          0
<OVERDISTRIBUTION-NII>                                             0
<ACCUMULATED-NET-GAINS>                                   10,711,316
<OVERDISTRIBUTION-GAINS>                                           0
<ACCUM-APPREC-OR-DEPREC>                                 318,799,745
<NET-ASSETS>                                             485,582,570
<DIVIDEND-INCOME>                                             14,033
<INTEREST-INCOME>                                          2,065,374
<OTHER-INCOME>                                                     0
<EXPENSES-NET>                                             5,135,566
<NET-INVESTMENT-INCOME>                                   (3,056,159)
<REALIZED-GAINS-CURRENT>                                  35,694,901
<APPREC-INCREASE-CURRENT>                                253,975,089
<NET-CHANGE-FROM-OPS>                                    286,613,831
<EQUALIZATION>                                                     0
<DISTRIBUTIONS-OF-INCOME>                                          0
<DISTRIBUTIONS-OF-GAINS>                                  34,646,099
<DISTRIBUTIONS-OTHER>                                              0
<NUMBER-OF-SHARES-SOLD>                                            0
<NUMBER-OF-SHARES-REDEEMED>                                        0
<SHARES-REINVESTED>                                          347,843
<NET-CHANGE-IN-ASSETS>                                   276,062,943
<ACCUMULATED-NII-PRIOR>                                            0
<ACCUMULATED-GAINS-PRIOR>                                          0
<OVERDISTRIB-NII-PRIOR>                                            0
<OVERDIST-NET-GAINS-PRIOR>                                         0
<GROSS-ADVISORY-FEES>                                      4,590,869
<INTEREST-EXPENSE>                                                 0
<GROSS-EXPENSE>                                            5,135,566
<AVERAGE-NET-ASSETS>                                               0
<PER-SHARE-NAV-BEGIN>                                         21.771
<PER-SHARE-NII>                                               (0.290)
<PER-SHARE-GAIN-APPREC>                                        28.13
<PER-SHARE-DIVIDEND>                                               0
<PER-SHARE-DISTRIBUTIONS>                                      3.465
<RETURNS-OF-CAPITAL>                                               0
<PER-SHARE-NAV-END>                                           46.146
<EXPENSE-RATIO>                                                 1.45



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission